Sage Therapeutics Inc (SAGE) — Capital Reinvestment Ratio
Sage Therapeutics Inc (SAGE) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow ($1.01 Billion) in capital expenditures ($1.00K). See SAGE equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sage Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Sage Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check SAGE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sage Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Sage Therapeutics Inc from 2020 to 2020. For live market cap and broader valuation context, see Sage Therapeutics Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.00x | $664.28 Million | $345.00K | — |